Dosing of the first patient in the RIVER-81 Phase II study of RVU120 in combination with venetoclax
TitleFile
Current Report ESPI 5/2024
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy